thousand sources of Shanxi Pharmaceutical Co., Ltd. (the "Company") is a thousand sources of Shanxi Pharmaceutical Co., Ltd. established the overall change at the June 6, 2010 by the Shanxi Datong Industry and Commerce Administration approved the registration, obtain the registration number is "140200400002021" and "business license", the registered capital of 10,000 ten thousand yuan ; registered address for the Datong Economic Development Zone No. 53 Lake Street; covers an area of 120 acres. The approved business scope: production and sales of bulk drugs, powder (including penicillins, cephalosporins), tablets (including penicillins, cephalosporins), hard capsules (including penicillins, cephalosporins ), granules (including penicillins), powder, suppository, psychotropic drugs (diazepam tablets, Ace Ventura alprazolam tablets, nitrazepam tablets, diazepam injection); production and sales of fine chemical raw materials (excluding hazardous chemical products, explosives) (National Prohibition special exception approval).

Company is development, production and sales of anti-infective pharmaceutical science and technology-based enterprises, Shanxi Science and Technology, Shanxi Province Department of Finance, State Administration of Taxation of Shanxi Province, Shanxi Province Local Taxation Bureau jointly identified high-tech enterprises, with 10 new drug certificate products, Drug Approval No. 272. Company to provide solutions to the problem of bacterial resistance to anti-infective products and integrated solutions for the strategic core, the current generation of penicillin in the field with a strong competitive edge. The main products are injectable mezlocillin sulbactam injection amoxicillin sulbactam, amoxicillin and clavulanate potassium tablets, Amoxicillin Sodium and Clavulanate Potassium for injection mezlocillin sodium injection azlocillin sodium, aztreonam for injection, metronidazole disodium phosphate injection, fosfomycin tromethamine bulk, fluoxetine capsules, tablets sertraline hydrochloride, ambroxol hydrochloride dispersed tablets, ginkgo biloba tablet, etc., in which injection amoxicillin sulbactam, metronidazole disodium phosphate injection is the first domestic species listed drug, aztreonam injection for the types of domestic generic drugs, first approved .

manufactures and sells variety of drugs, with many edge species, five varieties of market share in 2009, the top three ranks, comprehensive and competitive products. The company has 272 pharmaceutical production symbol, the 81 varieties included in the "Essential Drugs List", 189 species included in the "national health insurance directory." 2009, 2010, the company products mezlocillin sulbactam, ambroxol tablet after another was "Health News" as "drugs ease the minds of the people" and "most people concerned about the drugs."

in marketing to create a unique "fine record value investment model ', is the growing realization of the value of the dealer, from the investment strategy, tactics to establish two levels between the company and distributors collaboration, integration consultants and service sales model refinement. Through this model, companies end dealers to promote improved value-added products, better control of the marketing aspects of the whole value chain process, as the basis for the company has established a professional marketing team and marketing network in the country has more than 2,200 dealers, sales coverage of more than 10,000 terminals.

since the company was established since 2005, after six years of entrepreneurial growth, sales volume in 2010 reached 320 million in 2009, has become one of the market and semi-synthetic penicillin penicillin compound top ten markets in the the field of private-funded enterprises in the first place.